rs145556855
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001128228.3(TPRN):c.1906C>T(p.Arg636Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000436 in 1,605,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R636R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001128228.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TPRN | NM_001128228.3 | c.1906C>T | p.Arg636Trp | missense_variant | 2/4 | ENST00000409012.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TPRN | ENST00000409012.6 | c.1906C>T | p.Arg636Trp | missense_variant | 2/4 | 1 | NM_001128228.3 | P1 | |
TPRN | ENST00000477345.1 | n.2627C>T | non_coding_transcript_exon_variant | 1/3 | 1 | ||||
TPRN | ENST00000333046.8 | c.1300C>T | p.Arg434Trp | missense_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.000394 AC: 60AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000291 AC: 68AN: 233746Hom.: 0 AF XY: 0.000315 AC XY: 40AN XY: 127088
GnomAD4 exome AF: 0.000441 AC: 641AN: 1453794Hom.: 0 Cov.: 31 AF XY: 0.000444 AC XY: 321AN XY: 722638
GnomAD4 genome ? AF: 0.000394 AC: 60AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.000404 AC XY: 30AN XY: 74346
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 08, 2021 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Feb 17, 2022 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 636 of the TPRN protein (p.Arg636Trp). This variant is present in population databases (rs145556855, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with TPRN-related conditions. ClinVar contains an entry for this variant (Variation ID: 504686). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 22, 2017 | The p.Arg636Trp variant in TPRN has been previously reported by our laboratory i n the heterozygous state in one individual with hearing loss due to an alternate genetic etiology. It has also been identified in 67/117276 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; d bSNP rs145556855). Although this variant has been seen in the general population , its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analysis suggest that the p.Arg636Trp variant may impact the protein, though this information is not predictive enough to dete rmine pathogenicity. In summary, the clinical significance of the p.Arg636Trp va riant is uncertain. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2022 | The c.1906C>T (p.R636W) alteration is located in exon 2 (coding exon 2) of the TPRN gene. This alteration results from a C to T substitution at nucleotide position 1906, causing the arginine (R) at amino acid position 636 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at